Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2018 Filed Apr 17, 2018 20:44 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 82 | $60.42 | $4,954.44 |
DisclosureSEC source: 0000721371-18-000032 · wf-form4_152399787104883.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 Underlying: Common Shares · 82 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| February 20, 2018 Filed Feb 20, 2018 22:54 UTC |
Giacomin Jon LCEO, Medical Segment
|
SaleCommon Shares | 2,271 | $69.12 | $156,971.52 |
DisclosureSEC source: 0000721371-18-000027 · wf-form4_151916722984024.xml · nonDerivative · entry 3 Giacomin Jon L · CIK 0001623254 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,048 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.03 to $69.20, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 20, 2018 22:54 UTC |
Giacomin Jon LCEO, Medical Segment
|
SaleCommon Shares | 5,724 | $68.65 | $392,952.60 |
DisclosureSEC source: 0000721371-18-000027 · wf-form4_151916722984024.xml · nonDerivative · entry 2 Giacomin Jon L · CIK 0001623254 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,319 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $69.00, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 14:06 UTC |
MORRISON PATRICIAChief Information Officer
|
Tax withholdingCommon Shares | 1,179 | $67.34 | $79,393.86 |
DisclosureSEC source: 0000721371-18-000025 · wf-form4_151878996175073.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,978 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 3,804 restricted share units. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 22:54 UTC |
Giacomin Jon LCEO, Medical Segment
|
GrantCommon Shares | 14,684 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-18-000027 · wf-form4_151916722984024.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,043 F1 · kind: Grant of restricted share units that vest on February 15, 2019. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 14:06 UTC |
MORRISON PATRICIAChief Information Officer
|
SaleCommon Shares | 28,532 | $66.30 | $1,891,671.60 |
DisclosureSEC source: 0000721371-18-000025 · wf-form4_151878996175073.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,157 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.01 to $66.79, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 22:32 UTC |
Kaufmann Michael CDirector · Chief Executive Officer
|
SaleCommon Shares | 18,586 | $73.90 | $1,373,505.40 |
DisclosureSEC source: 0000721371-18-000015 · wf-form4_151674676482009.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,849 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted by the reporting person on August 25, 2017. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:12 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 69 | $71.49 | $4,932.81 |
DisclosureSEC source: 0000721371-18-000013 · wf-form4_151622354491501.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760 Underlying: Common Shares · 69 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on January 12, 2018. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:08 UTC |
ANDERSON DAVID JDirector
|
GrantPhantom Stock · Derivative | 34 | $71.49 | $2,430.66 |
DisclosureSEC source: 0000721371-18-000011 · wf-form4_151622332016274.xml · derivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Underlying: Common Shares · 34 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on January 12, 2018. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:05 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
Tax withholdingCommon Shares | 934 | $71.49 | $66,771.66 |
DisclosureSEC source: 0000721371-18-000009 · wf-form4_151622313744753.xml · nonDerivative · entry 1 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,998 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,889 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 22:27 UTC | Tax withholdingCommon Shares | 551 | $59.19 | $32,613.69 |
DisclosureSEC source: 0000721371-17-000177 · wf-form4_151242644359873.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,435 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on transaction date. Read SEC document |
|
| December 01, 2017 Filed Dec 4, 2017 22:24 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
Tax withholdingCommon Shares | 43 | $59.19 | $2,545.17 |
DisclosureSEC source: 0000721371-17-000175 · wf-form4_151242623438519.xml · nonDerivative · entry 1 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,406 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on transaction date. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 21:15 UTC |
Morford Craig SChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 285 | $57.07 | $16,264.95 |
DisclosureSEC source: 0000721371-17-000173 · wf-form4_151086691628452.xml · nonDerivative · entry 1 Morford Craig S · CIK 0001434592 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,873 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,678 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:47 UTC | GrantCommon Shares | 49,188 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000167 · wf-form4_151026761754125.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,986 F1 · kind: Grant of restricted share units that vest in three equal annual installments beginning on November 8, 2018. Read SEC document |
|
| November 08, 2017 Filed Nov 9, 2017 22:45 UTC |
Hall Patricia HemingwayDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000165 · wf-form4_151026751781957.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,558 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:43 UTC |
JONES CLAYTON MDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000163 · wf-form4_151026739554947.xml · nonDerivative · entry 1 JONES CLAYTON M · CIK 0001191566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,964 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:38 UTC |
KENNY GREGORY BDirector
|
GrantCommon Shares | 2,951 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000161 · wf-form4_151026710617989.xml · nonDerivative · entry 1 KENNY GREGORY B · CIK 0001179497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,648 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:36 UTC |
KING DAVID PDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000159 · wf-form4_151026698478525.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,044 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:32 UTC |
COX CARRIE SMITHDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000157 · wf-form4_151026676086511.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,687 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:30 UTC |
Killefer NancyDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000155 · wf-form4_151026662604728.xml · nonDerivative · entry 1 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,918 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:28 UTC |
DOWNEY BRUCEDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000153 · wf-form4_151026650886565.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,985 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:26 UTC |
Arnold Colleen F.Director
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000151 · wf-form4_151026640572328.xml · nonDerivative · entry 1 Arnold Colleen F. · CIK 0001409123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,515 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:23 UTC |
ANDERSON DAVID JDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000149 · wf-form4_151026621518628.xml · nonDerivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,946 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:20 UTC |
DARDEN CALVINDirector
|
GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000147 · wf-form4_151026601218754.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,689 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| October 16, 2017 Filed Oct 17, 2017 21:12 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 76 | $64.96 | $4,936.96 |
DisclosureSEC source: 0000721371-17-000132 · wf-form4_150827473567422.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,690 Underlying: Common Shares · 76 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on October 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| October 16, 2017 Filed Oct 17, 2017 21:10 UTC |
ANDERSON DAVID JDirector
|
GrantPhantom Stock · Derivative | 38 | $64.96 | $2,468.48 |
DisclosureSEC source: 0000721371-17-000130 · wf-form4_150827464146037.xml · derivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101 Underlying: Common Shares · 38 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing price on October 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:42 UTC | Tax withholdingCommon Shares | 6,331 | $67.46 | $427,089.26 |
DisclosureSEC source: 0000721371-17-000118 · wf-form4_150576734192425.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,798 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 13,341 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
|
| September 15, 2017 Filed Sep 18, 2017 20:40 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
Tax withholdingCommon Shares | 110 | $67.46 | $7,420.60 |
DisclosureSEC source: 0000721371-17-000116 · wf-form4_150576723199450.xml · nonDerivative · entry 1 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 334 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:35 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 845 | $67.46 | $57,003.70 |
DisclosureSEC source: 0000721371-17-000114 · wf-form4_150576674460731.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,359 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,779 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:30 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
Tax withholdingCommon Shares | 4,748 | $67.46 | $320,300.08 |
DisclosureSEC source: 0000721371-17-000112 · wf-form4_150576661964462.xml · nonDerivative · entry 1 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,503 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 10,006 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:52 UTC | GrantEmployee Stock Option (right to buy) · Derivative | 70,102 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000108 · wf-form4_150300672403145.xml · derivative · entry 4 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,102 Underlying: Common Shares · 70,102 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
|
| August 15, 2017 Filed Aug 17, 2017 21:52 UTC | Tax withholdingCommon Shares | 9,304 | $66.76 | $621,135.04 |
DisclosureSEC source: 0000721371-17-000108 · wf-form4_150300672403145.xml · nonDerivative · entry 2 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,129 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,180 RSUs and 13,034 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
|
| August 15, 2017 Filed Aug 17, 2017 21:52 UTC | GrantCommon Shares | 14,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000108 · wf-form4_150300672403145.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,433 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
|
| August 15, 2017 Filed Aug 17, 2017 21:50 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,149 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000106 · wf-form4_150300660037011.xml · derivative · entry 3 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,149 Underlying: Common Shares · 6,149 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:50 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
Tax withholdingCommon Shares | 855 | $66.76 | $57,079.80 |
DisclosureSEC source: 0000721371-17-000106 · wf-form4_150300660037011.xml · nonDerivative · entry 2 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,559 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,053 RSUs and 1,552 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:50 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
GrantCommon Shares | 1,254 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000106 · wf-form4_150300660037011.xml · nonDerivative · entry 1 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,414 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:47 UTC |
Barrett George SDirector · Chairman and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 233,673 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000104 · wf-form4_150300645500841.xml · derivative · entry 3 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,673 Underlying: Common Shares · 233,673 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:47 UTC |
Barrett George SDirector · Chairman and CEO
|
Tax withholdingCommon Shares | 43,168 | $66.76 | $2,881,895.68 |
DisclosureSEC source: 0000721371-17-000104 · wf-form4_150300645500841.xml · nonDerivative · entry 2 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,385 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 41,318 RSUs and 49,653 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:47 UTC |
Barrett George SDirector · Chairman and CEO
|
GrantCommon Shares | 47,669 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000104 · wf-form4_150300645500841.xml · nonDerivative · entry 1 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,553 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:42 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,102 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000102 · wf-form4_150300612332756.xml · derivative · entry 3 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,102 Underlying: Common Shares · 70,102 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:42 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
Tax withholdingCommon Shares | 6,285 | $66.76 | $419,586.60 |
DisclosureSEC source: 0000721371-17-000102 · wf-form4_150300612332756.xml · nonDerivative · entry 2 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,251 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 10,938 RSUs and 13,034 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:42 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
GrantCommon Shares | 14,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000102 · wf-form4_150300612332756.xml · nonDerivative · entry 1 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,536 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:39 UTC |
Morford Craig SChief Legal/Compliance Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 43,844 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000100 · wf-form4_150300594791953.xml · derivative · entry 3 Morford Craig S · CIK 0001434592 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,844 Underlying: Common Shares · 43,844 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:39 UTC |
Morford Craig SChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 1,349 | $66.76 | $90,059.24 |
DisclosureSEC source: 0000721371-17-000100 · wf-form4_150300594791953.xml · nonDerivative · entry 2 Morford Craig S · CIK 0001434592 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,158 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,598 RSUs and 7,448 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:39 UTC |
Morford Craig SChief Legal/Compliance Officer
|
GrantCommon Shares | 8,944 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000100 · wf-form4_150300594791953.xml · nonDerivative · entry 1 Morford Craig S · CIK 0001434592 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,507 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:36 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,102 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000098 · wf-form4_150300577154679.xml · derivative · entry 3 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,102 Underlying: Common Shares · 70,102 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:36 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 8,243 | $66.76 | $550,302.68 |
DisclosureSEC source: 0000721371-17-000098 · wf-form4_150300577154679.xml · nonDerivative · entry 2 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,204 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 7,645 RSUs and 10,976 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:36 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
GrantCommon Shares | 14,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000098 · wf-form4_150300577154679.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,447 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC |
MORRISON PATRICIAChief Information Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,517 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · derivative · entry 3 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,517 Underlying: Common Shares · 29,517 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC |
MORRISON PATRICIAChief Information Officer
|
Tax withholdingCommon Shares | 3,862 | $66.76 | $257,827.12 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,689 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,922 RSUs and 6,827 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.